Charles River Laboratories International, Inc. (CRL) Stock Overview
NYSE · Healthcare · Diagnostics & Research
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats…
Source: Yahoo Finance
Sector & Industry
Charles River Laboratories International, Inc. operates in the Healthcare sector, within the Diagnostics & Research industry group. It is listed on the NYSE exchange.
Charles River Laboratories International, Inc. at a Glance
| Company | Charles River Laboratories International, Inc. |
| Ticker | CRL |
| Exchange | NYSE |
| Currency | USD |
| Price | $288.50 |
| Market cap | $13.90B |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$4.82 |
| 52-week high | $303.31 |
| 52-week low | $144.26 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 1.41 |
| Return on equity (ROE) | -7.52% |
| Debt-to-equity | 105.05% |
| Average volume | 890,960 |
| Shares outstanding | 48.17M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Employees | 18,300 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Frequently Asked Questions
- What is Charles River Laboratories International, Inc.'s current P/E ratio?
- Charles River Laboratories International, Inc. (CRL) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Charles River Laboratories International, Inc.'s market capitalisation?
- Charles River Laboratories International, Inc.'s market cap is $13.90B based on our latest snapshot. See how it ranks by market cap →
- What is CRL's 52-week range?
- Over the past 52 weeks, CRL has traded between $144.26 and $303.31. What does the 52-week range mean? →
- How volatile is Charles River Laboratories International, Inc. compared to the market?
- Charles River Laboratories International, Inc. has a beta of 1.41, meaning it has historically moved more than the broader market. What does beta measure? →
- Does Charles River Laboratories International, Inc. pay a dividend?
- Charles River Laboratories International, Inc. does not currently pay a dividend according to our latest data.
- What exchange is CRL listed on?
- CRL is listed on the NYSE. Browse all NYSE-listed stocks →
- What sector is Charles River Laboratories International, Inc. in?
- Charles River Laboratories International, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Working out potential returns or position sizes? Our payout and odds calculators handle the maths.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →